Trinity Biotech plc to Announce Second Quarter Fiscal Year 2017 Financial Results
July 03 2017 - 7:57AM
Trinity Biotech plc (Nasdaq:TRIB), a leading developer and
manufacturer of diagnostic products for the point-of-care and
clinical laboratory markets, will report financial results for the
second quarter fiscal year 2017 on Thursday, July 20, 2017. The
Company has scheduled a conference call for that same day,
Thursday, July 20, 2017 at 11:00am ET (4:00pm BST) to discuss the
results of the quarter.
Interested parties can access the call by
dialing:
|
USA: |
|
1-844-861-5499 |
|
International: |
|
1-412-317-6581 |
|
Conference ID #: |
|
10110132 |
A simultaneous webcast of the call can be
accessed at:https://www.webcaster4.com/Webcast/Page/1135/21731
A replay of the call can be accessed until July
27, 2017 by dialing:
|
USA: |
|
1-877-344-7529 |
|
International: |
|
1-412-317-0088 |
|
Conference ID #: |
|
110110132 |
The webcast of the call will be available for 30
days at:https://www.webcaster4.com/Webcast/Page/1135/21731
Forward-looking statements in this release are
made pursuant to the "safe harbor" provision of the Private
Securities Litigation Reform Act of 1995. Investors are cautioned
that such forward-looking statements involve risks and
uncertainties including, but not limited to, the results of
research and development efforts, the effect of regulation by the
United States Food and Drug Administration and other agencies, the
impact of competitive products, product development
commercialisation and technological difficulties, and other risks
detailed in the Company's periodic reports filed with the
Securities and Exchange Commission.
Trinity Biotech develops, acquires, manufactures
and markets diagnostic systems, including both reagents and
instrumentation, for the point-of-care and clinical laboratory
segments of the diagnostic market. The products are used to detect
infectious diseases and to quantify the level of Haemoglobin A1c
and other chemistry parameters in serum, plasma and whole blood.
Trinity Biotech sells direct in the United States, Germany, France
and the U.K. and through a network of international distributors
and strategic partners in over 75 countries worldwide. For further
information please see the Company's website:
www.trinitybiotech.com.
Contact:
Trinity Biotech plc
Kevin Tansley
(353)-1-2769800
E-mail: kevin.tansley@trinitybiotech.com
Lytham Partners LLC
Joe Diaz, Joe Dorame & Robert Blum
602-889-9700
Trinity Biotech (NASDAQ:TRIB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Trinity Biotech (NASDAQ:TRIB)
Historical Stock Chart
From Sep 2023 to Sep 2024